Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:168
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size

Table of Contents   
Year : 2017  |  Volume : 10  |  Issue : 2  |  Page : 297-298
Uniting the efforts of stakeholders to end tuberculosis globally by 2030

Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Kancheepuram, Tamil Nadu, India

Click here for correspondence address and email

Date of Web Publication22-Jun-2017

How to cite this article:
Shrivastava SR, Shrivastava PS, Ramasamy J. Uniting the efforts of stakeholders to end tuberculosis globally by 2030. Ann Trop Med Public Health 2017;10:297-8

How to cite this URL:
Shrivastava SR, Shrivastava PS, Ramasamy J. Uniting the efforts of stakeholders to end tuberculosis globally by 2030. Ann Trop Med Public Health [serial online] 2017 [cited 2020 Jul 7];10:297-8. Available from:
2015 marks an important year, a year in which the global stakeholders have moved forward from Millennium Development Goals to the Sustainable Development Goals (SDGs).[1] Ambitious goals have been proposed under the SDGs to be achieved over the next 15 years in an attempt to ensure that the majority of the health-related conditions are addressed well.[1] With regard to tuberculosis (TB), the aim of the adopted WHO end-TB strategy is to decrease incidence by four-fifths and death rates by 90% till the year 2030 and to ensure that no household affected by the disease is exposed to the catastrophic costs attributed to the disease.[1],[2]

Even though a significant progress in the battle against the disease has been achieved with the lives of more than 40 million people being saved, still it remains one of the leading infectious causes of deaths, accounting for almost 4000 people deaths every day worldwide.[1],[3] In fact, 9.6 million and 1.5 million people, were diagnosed with the infection and died due to the disease in the year 2014 respectively, with more than 95% of deaths being reported among the poor, vulnerable, and marginalized people.[3]

Most of the case burden or associated fatality has been attributed to the presence of existing challenges such as fragile health care delivery systems, poor awareness among the general population, insufficient advocacy around TB, dearth of health professionals or outreach workers, financial constraints due to the under-investment by the government, emergence of drug-resistant forms of TB, lack of collaboration with different stakeholders, poor implementation of the program, defects in the monitoring and supervision activities, co-existence of diseases such as HIV and diabetes, and limited research activities in various unexplored areas of TB.[1],[3],[4],[5]

The probability to achieve the target to end TB can be enhanced to a great extent, provided there is an extensive collaboration within and across the governments, and with other stakeholders including members of the communities and funding agencies.[2] In addition, the high burden nations should aim to improve the strategic agendas of their national programs, by not only ensuring adoption of newer, cost-effective tools but extending access to care and fostering linkages with multiple partners to eventually minimize the financial expenses borne by the patients or their family members.[3],[4],[5]

Further, initiatives to fast-track the development of newer diagnostic tests, drugs or vaccines, and to implement successful strategies to improve the delivery is also bound to deliver quite effective results.[1],[2],[3] In fact, a large number of high-burden nations have come up with solutions like introduction of bedaquiline in treatment regimen to contain multidrug-resistant-TB or declaring TB as a notifiable disease in India; expansion of GenXpert molecular diagnostic tool in South Africa; ensuring access to health services to all at minimal cost in Thailand; and strengthening of the existing policies in Russia.[1],[2]

To conclude, in the global mission to end the disease by 2030, there is an extensive need to formulate strong policies and supportive systems, ensure delivery of integrated patient-centered care and prevention activities, unite all stakeholders, and invest in the intensified research and innovation activities.

   References Top

World Health Organization. On the road to ending TB: Highlights from the 30 highest TB burden countries. Geneva: WHO Press; 2016. p. 1-11.  Back to cited text no. 1
Uplekar M, Raviglione M. WHO's end TB strategy: From stopping to ending the global TB epidemic. Indian J Tuberc 2015;62:196-9.  Back to cited text no. 2
World Health Organization. Global Tuberculosis Report. Geneva: WHO Press; 2015. p. 1-26.  Back to cited text no. 3
Pai M, Daftary A, Satyanarayana S. TB control: Challenges and opportunities for India. Trans R Soc Trop Med Hyg 2016;110:158-60.  Back to cited text no. 4
Kunii O, Yassin MA, Wandwalo E. Investing to end epidemics: The role of the global fund to control TB by 2030. Trans R Soc Trop Med Hyg 2016;110:153-4.  Back to cited text no. 5

Correspondence Address:
Saurabh RamBihariLal Shrivastava
Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, 3rd Floor, Ammapettai Village, Thiruporur - Guduvancherry Main Road, Sembakkam Post, Kancheepuram, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1755-6783.196836

Rights and Permissions


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


 Article Access Statistics
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal